Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barni

Showing results (121-130 of 369) with videos related to

Pageof 37
Sort By:
Journal of Biological Regulators and Homeostatic Agents|April 1, 1995
Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II studyP Lissoni, S Barni, F Brivio, et al.
The International Journal of Biological Markers|April 1, 1991
Blood levels of IGF-I in non-small cell lung cancer: relation to clinical dataE Tisi, P Lissoni, F Rovelli, et al.
Histology and Histopathology|January 7, 2011
Comparative pulmonary toxicity assessment of pristine and functionalized multi-walled carbon nanotubes intratracheally instilled in rats: morphohistochemical evaluationsE Roda, T Coccini, D Acerbi, et al.
Tumori|February 28, 1990
A study of the pineal hormone melatonin as a second line therapy in metastatic colorectal cancer resistant to fluorouracil plus folatesS Barni, P Lissoni, F Paolorossi, et al.
Anticancer Research|May 1, 1995
DNA-protein cell content of lymphokine activated killer (LAK) and target cells in cocultureR Nano, S Barni, E Capelli, et al.
Cancer|February 1, 1994
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasmsP Lissoni, S Barni, A Ardizzoia, et al.
European Journal of Histochemistry : EJH|November 30, 2000
Cytoskeleton actin changes in IL-2 activated cellsE Capelli, R Nano, S Panelli, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1994
Weekly epirubicin plus low-dose interleukin-2 subcutaneous therapy in breast cancer: preliminary immunobiological resultsP Lissoni, S Barni, A Ardizzoia, et al.
Tumori|August 31, 1990
Severe hypotension in disseminated colon cancer due to a possible decreased dopamine brain content: a case reportP Lissoni, S Barni, S Meregalli, et al.
The International Journal of Biological Markers|July 1, 1997
Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: preliminary observationsP Lissoni, F Rovelli, L Fumagalli, et al.
Pageof 37

Showing results (121-130 of 369) with videos related to

Sort By:
Pageof 37
Journal of Biological Regulators and Homeostatic Agents|April 1, 1995
Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II studyP Lissoni, S Barni, F Brivio, et al.
The International Journal of Biological Markers|April 1, 1991
Blood levels of IGF-I in non-small cell lung cancer: relation to clinical dataE Tisi, P Lissoni, F Rovelli, et al.
Histology and Histopathology|January 7, 2011
Comparative pulmonary toxicity assessment of pristine and functionalized multi-walled carbon nanotubes intratracheally instilled in rats: morphohistochemical evaluationsE Roda, T Coccini, D Acerbi, et al.
Tumori|February 28, 1990
A study of the pineal hormone melatonin as a second line therapy in metastatic colorectal cancer resistant to fluorouracil plus folatesS Barni, P Lissoni, F Paolorossi, et al.
Anticancer Research|May 1, 1995
DNA-protein cell content of lymphokine activated killer (LAK) and target cells in cocultureR Nano, S Barni, E Capelli, et al.
Cancer|February 1, 1994
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasmsP Lissoni, S Barni, A Ardizzoia, et al.
European Journal of Histochemistry : EJH|November 30, 2000
Cytoskeleton actin changes in IL-2 activated cellsE Capelli, R Nano, S Panelli, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1994
Weekly epirubicin plus low-dose interleukin-2 subcutaneous therapy in breast cancer: preliminary immunobiological resultsP Lissoni, S Barni, A Ardizzoia, et al.
Tumori|August 31, 1990
Severe hypotension in disseminated colon cancer due to a possible decreased dopamine brain content: a case reportP Lissoni, S Barni, S Meregalli, et al.
The International Journal of Biological Markers|July 1, 1997
Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: preliminary observationsP Lissoni, F Rovelli, L Fumagalli, et al.
Pageof 37